bluebird bio: This Winner Has A Bright 2018 Outlook

Shares of bluebird bio (NASDAQ:BLUE) have more than doubled since my initial February piece stating shares were set to fly higher, and have risen by around 50% since my August update.

ChartBLUE data by YCharts

Previously mentioned keys to the bullish thesis included the following:

READ FULL ARTICLE HERE

It's on us. Share your news here.

Submit your stories and articles to citybizlist today.